New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
November 11, 2009
11:48 EDTEW
theflyonthewall.com: Edwards Lifesciences CEO says 2010 sales growth likely to exceed 10%
The CEO says the company hopes to submit partner study data to the FDA by late summer/early fall 2010 and says transcatheter heart valves could be available in the U.S, Reuters reports. :theflyonthewall.com



News For EW From The Last 14 Days
Check below for free stories on EW the last two weeks.
There are 22 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 3, 2012
12:26 EDTEW
theflyonthewall.com: On The Fly: Mid-Day Wrap

Subscribe for More Information
:theflyonthewall.com
12:00 EDTEW
theflyonthewall.com: Edwards Lifesciences falls 11.2%
Edwards Lifesciences is down 11.2%, or $9.05, to $71.62 :theflyonthewall.com
11:26 EDTEW
theflyonthewall.com: Edwards sinks after Q1 guidance misses expectations
Edwards Lifesciences (EW) reported Q4 adjusted EPS of 62c, compared with analysts' consensus estimate of 59c. The adjusted EPS excludes several items, including a pre-tax $17.6M special charge related to southern European receivables risk, a global realignment charge and a legal settlement. The company's revenue came in lower than expected. Moreover, Edwards provided Q1 adjusted EPS guidance of 47c-49c, versus the consensus estimate of 55c, and the company expects its Q1 revenue to also come in lower than expected. Edwards' Q1 EPS guidance excludes several special items, the company said. Edwards reiterated its 2012 EPS guidance of $2.70-$2.80, excluding special items, as well as its 2012 transcatheter heart valve sales guidance of $560M-$630M. Edwards' guidance assumes a mid-year 2012 approval of Cohort A of the Partner Trial of its Sapien heart valve, the company said. "We have just begun offering our life saving Sapien technology to many inoperable U.S. patients suffering from severe aortic stenosis and also anticipate making it available for patients whose conditions place them at high risk for surgery," said Edwards CEO Michael Mussallem. In a note to investors, Jefferies recommended buying the stock on weakness today, as the firm believes that the company's outlook is largely unchanged following the results. Jefferies maintains a positive bias and Buy rating on the stock. In late morning trading, Edward dropped $9.36, or 11.60%, to $71.31. :theflyonthewall.com
10:31 EDTEW
theflyonthewall.com: On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Research in Motion (RIMM) downgraded to Underperform from Hold at Jefferies...Cablevision (CVC) downgraded to Underweight from Neutral at JP Morgan...Edwards Lifesciences (EW) downgraded to Market Perform from Outperform at Wells Fargo...Rofin-Sinar (RSTI) downgraded to Neutral from Overweight at Piper Jaffray...Kforce (KFRC) downgraded to Hold from Buy at Deutsche Bank...Airgas (ARG) downgraded to Neutral from Buy at Goldman...Vertex Pharmaceuticals (VRTX) downgraded to Neutral from Buy at Goldman...Aetna (AET) downgraded to Buy from Conviction Buy at Goldman...Amerigroup (AGP) downgraded to Neutral from Buy at Goldman...ONEOK (OKE) downgraded to Neutral from Buy at Citigroup...Acme Packet (APKT) downgraded to Underperform from Neutral at Mizuho...RadioShack (RSH) downgraded to Equal Weight from Overweight at Morgan Stanley...Brocade (BRCD) downgraded to Market Perform from Outperform at JMP Securities...Merck (MRK) downgraded to Neutral from Buy at Davenport...CarMax (KMX) downgraded to Sector Perform from Outperform at RBC Capital...International Paper (IP) downgraded to Sector Perform from Outperform at RBC Capital...Abercrombie & Fitch (ANF) downgraded to Neutral from Outperform at Macquarie...Rowan Companies (RDC) downgraded to Neutral from Outperform at Macquarie. :theflyonthewall.com
10:07 EDTEW
theflyonthewall.com: Corrected: Gappers reports
The gapping stocks reports this morning included stocks that traded below $10. All other aspects of the stories remain the same. :theflyonthewall.com
10:01 EDTEW
theflyonthewall.com: Gappers report: Bearish gaps

Subscribe for More Information
:theflyonthewall.com
09:38 EDTEW
theflyonthewall.com: Edwards Lifesciences shares defended at Goldman
:theflyonthewall.com
09:00 EDTEW
theflyonthewall.com: Edwards Lifesciences falls 8.3%

Subscribe for More Information
:theflyonthewall.com
08:14 EDTEW
theflyonthewall.com: Edwards Lifesciences shares should be bought on weakness, says RBC Capital

Subscribe for More Information
:theflyonthewall.com
07:39 EDTEW
theflyonthewall.com: Government report says some hospitals overpay for devices, WSJ says

Subscribe for More Information
:theflyonthewall.com
07:10 EDTEW
theflyonthewall.com: Edwards Lifesciences pullback a buying opportunity, says Jefferies

Subscribe for More Information
:theflyonthewall.com
05:46 EDTEW
theflyonthewall.com: Edwards Lifesciences downgraded to Market Perform from Outperform at Wells Fargo

Subscribe for More Information
:theflyonthewall.com

February 2, 2012
16:09 EDTEW
theflyonthewall.com: Edwards Lifesciences backs FY12 revenue view $1.95B-$2.05B vs. consensus $2.01B

Subscribe for More Information
:theflyonthewall.com
16:09 EDTEW
theflyonthewall.com: Edwards Lifesciences sees Q1 adjusted EPS 47c-49c vs. consensus 55c

Subscribe for More Information
:theflyonthewall.com
16:07 EDTEW
theflyonthewall.com: Edwards Lifesciences reports Q4 adjusted EPS 62c vs. consensus 59c

Subscribe for More Information
:theflyonthewall.com
15:12 EDTEW
theflyonthewall.com: Companies reporting After the Market Close on Thursday, February 2

Subscribe for More Information
:theflyonthewall.com
14:05 EDTEW
theflyonthewall.com: FDA and industry reach agreement in principle on medical device user fees
The FDA and representatives from the medical device industry have reached an agreement in principle on proposed recommendations for the third reauthorization of a medical device user fee program. The recommendations would authorize the FDA to collect $595M in user fees over five years, plus adjustments for inflation. Details of the agreement, such as the fee structure, are expected to be finalized soon. :theflyonthewall.com
10:19 EDTEW
theflyonthewall.com: On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Autoliv (ALV) downgraded to Sell from Buy at Citigroup...JDSU (JDSU) downgraded to Neutral from Buy at UBS...Vanguard Health (VHS) downgraded to Market Perform from Outperform at Wells Fargo...Steel Dynamics (STLD) downgraded to Neutral from Buy at BofA/Merrill...AK Steel (AKS) downgraded to Underperform from Neutral at BofA/Merrill...Northrop Grumman (NOC) downgraded to Underperform from Neutral at BofA/Merrill...Sykes Enterprises (SYKE) downgraded to Neutral from Outperform at RW Baird...NYSE Euronext (NYX) downgraded to Market Perform from Outperform at BMO Capital...QuinStreet (QNST) downgraded to Hold from Buy at ThinkEquity...Edwards Lifesciences (EW) downgraded to Neutral from Outperform at Credit Suisse...Ann Inc. (ANN) downgraded to Underweight from Neutral at Piper Jaffray...Johnson & Johnson (JNJ) downgraded to Market Perform from Outperform at First Global. :theflyonthewall.com
06:23 EDTEW
theflyonthewall.com: Edwards Lifesciences downgraded to Neutral from Outperform at Credit Suisse

Subscribe for More Information
:theflyonthewall.com

January 31, 2012
08:10 EDTEW
theflyonthewall.com: Edwards Lifesciences data removes major overhang, says RBC Capital

Subscribe for More Information
:theflyonthewall.com

January 30, 2012
16:17 EDTEW
theflyonthewall.com: Edwards Lifesciences announces positive results for transcatheter

Subscribe for More Information
:theflyonthewall.com
07:21 EDTEW
theflyonthewall.com: Society of Thoracic Surgeons to hold annual meeting

Subscribe for More Information
:theflyonthewall.com